Skip to main content

01.12.2014 | Case report | Ausgabe 1/2014 Open Access

BMC Cardiovascular Disorders 1/2014

Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation

BMC Cardiovascular Disorders > Ausgabe 1/2014
Tobias Kammerer, Andres Beiras-Fernandez, Markus Rehm, Manfred Stangl, Markus Guba, Christian Kupatt-Jeremias, Florian Weis
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2261-14-112) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

All authors were involved in the treatment of the patient. TK, AB, CKJ and FW contributed to the writing of the manuscript. All authors read and approved the final manuscript.



Kidney transplantation is the gold standard of therapy in patients with terminal renal insufficiency. Living donor transplantation is a well-established option in this field. Enlarging the donor’s pool implicates the acceptance of an increased rate of comorbidities. Among them, coronary artery disease is a growing problem. An increasing number of patients, undergoing living donation, receive antiplatelet therapies due to coronary disease.

Case presentation

Here we report about the perioperative treatment with a drug-eluting balloon in a patient with major cardiac risk factors who underwent kidney transplantation.


At the current time no recommendation can be given for the routine use of drug-eluting balloons.
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2014

BMC Cardiovascular Disorders 1/2014 Zur Ausgabe

Neu im Fachgebiet Kardiologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.